Corient Private Wealth
MRTX

Corient Private Wealth’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Corient Private Wealth’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-640
Closed -$23.8K – 2165
2023
Q1 		$23.8K Sell
640
-9,885
-94% -$368K ﹤0.01% 1953
2022
Q4 		$477K Buy
+10,525
New +$477K ﹤0.01% 1152